The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Presence of CD8+ cytotoxic T-cells in proximity to tumor cells, TIM3, CTLA-4 and prognostic implications for muscle-invasive urothelial cancer.
 
Nicolaus F. Debatin
No Relationships to Disclose
 
Henning Plage
No Relationships to Disclose
 
Tobias Klatte
No Relationships to Disclose
 
Sefer Elezkurtaj
No Relationships to Disclose
 
Paul G. Bruch
No Relationships to Disclose
 
Maria De Santis
Honoraria - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca/MedImmune; Basilea; Bayer; BioClin Therapeutics; Bristol-Myers Squibb; Exelixis/Ipsen; Ferring; Gilead Sciences; Immunomedics; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novartis; Orion; Pfizer; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen
Consulting or Advisory Role - AAA HealthCare; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Basilea; Bayer; BioClin Therapeutics; BioSyn Healthy Pharma; Bristol-Myers Squibb; Ferring; Gilead Sciences; GlaxoSmithKline; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Orion Health; Pierre Fabre; Roche/Genentech; Sandoz-Novartis; Sanofi; Seagen; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Roche; Roche/Genentech; Sanofi
 
David Horst
No Relationships to Disclose
 
Andreas H. Marx
No Relationships to Disclose
 
Margit Fisch
Consulting or Advisory Role - Boston Scientific (Inst)
Research Funding - Boston Scientific (Inst)
Travel, Accommodations, Expenses - Takeda
 
Marcin Slojewski
No Relationships to Disclose
 
Krystian Kaczmarek
No Relationships to Disclose
 
Thorsten Ecke
No Relationships to Disclose
 
Steffen Hallmann
No Relationships to Disclose
 
Stefan Koch
No Relationships to Disclose
 
Nico Adamini
No Relationships to Disclose
 
Maximilian Lennartz
No Relationships to Disclose
 
Guido Sauter
Leadership - The TIM3, PD-L1, CTLA-4, CD20, CD4, panCK, Ki-67, CD31, HLA-DR, Myosin H11, Desmoglein3 and CDH16 antibody clones were provided by MS Validated Antibodies GmbH (owned by a family member of GS) (I)
Patents, Royalties, Other Intellectual Property - Patent #WO 2023/285518
 
Henrik Zecha
No Relationships to Disclose
 
Thorsten Schlomm
No Relationships to Disclose
 
Niclas C. Blessin
Patents, Royalties, Other Intellectual Property - Patent #WO 2023/285518